To prove that LIMA1 is an essential active molecule in LTH‐sEV, we observed the effect of LIMA1 knockdown in LTH‐sEV (sEVshLIMA1) on MASLD progression both in vitro and in vivo. This evidence concerns the gene LIMA1 and metabolic dysfunction-associated steatotic liver disease.